What are the recommended markers for diagnosing Leiomyosarcoma, particularly in an adult patient with a suspected tumor at the gastroesophageal junction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Leiomyosarcoma Immunohistochemical Markers

For diagnosing leiomyosarcoma, particularly at the gastroesophageal junction, the essential immunohistochemical panel should include smooth muscle actin (most sensitive at 95%), desmin, and caldesmin, with negative staining for CD117 and CD34 to distinguish from GIST. 1

Core Diagnostic Markers for Leiomyosarcoma

Primary Smooth Muscle Markers (in order of sensitivity)

  • Smooth muscle actin is the most sensitive marker with 95% positivity in leiomyosarcomas, making it the first-line screening marker 2, 3

  • Muscle-specific actin (HHF35) demonstrates 91% sensitivity and consistently stains all leiomyosarcomas regardless of differentiation 2, 3

  • Calponin shows 88% sensitivity and is expressed in the majority of leiomyosarcomas, with diffuse cytoplasmic staining throughout tumor cells 2, 3

  • Desmin is positive in 73-76% of cases, though less sensitive than actins; it is particularly useful when positive but its absence does not exclude leiomyosarcoma 1, 2, 3

  • h-Caldesmon demonstrates only 36-66% sensitivity overall but shows higher expression (94%) in retroperitoneal tumors; it is highly specific for smooth muscle differentiation when present 4, 3

  • Smooth muscle myosin is positive in 64% of cases and tends to be coexpressed with caldesmon, particularly in retroperitoneal locations 3

Critical Negative Markers to Distinguish from GIST

  • CD117 (c-kit) must be negative to differentiate leiomyosarcoma from GIST, as over 95% of GISTs express CD117 1

  • CD34 should be negative in leiomyosarcoma, whereas 70-90% of GISTs express CD34 1

  • DOG1 should be negative to exclude GIST, as this marker is highly specific for GIST and expressed even in some CD117-negative GISTs 1

  • S-100 protein should be negative to exclude neural origin tumors like schwannoma, which express S-100 in 8-10% of cases 1

Practical Diagnostic Algorithm

Step 1: Initial Screening Panel

  • Order smooth muscle actin, desmin, CD117, and CD34 as the initial panel 1
  • If smooth muscle actin is positive AND CD117/CD34 are negative, proceed to confirmatory markers 2, 3

Step 2: Confirmatory Panel

  • Add calponin, h-caldesmon, and muscle-specific actin to confirm smooth muscle differentiation 2, 4, 3
  • A diagnosis of leiomyosarcoma requires positivity for at least 2-3 smooth muscle markers with negative CD117 and CD34 1

Step 3: Additional Markers for Specific Clinical Contexts

  • In female patients with retroperitoneal or gastroesophageal junction tumors, consider adding estrogen receptor (ER) and progesterone receptor (PR), as these are positive in 63-86% of uterine and female retroperitoneal leiomyosarcomas 3
  • WT1 nuclear staining may be present in 11% of ER-positive uterine and female retroperitoneal tumors 3

Important Caveats and Pitfalls

Variable Expression Based on Differentiation

  • Well-differentiated leiomyosarcomas show more consistent expression of h-caldesmon and myosin compared to poorly differentiated tumors 4, 3
  • Poorly differentiated leiomyosarcomas, particularly in external soft tissues, may be h-caldesmon negative despite being true leiomyosarcomas 4
  • The absence of h-caldesmon does not exclude leiomyosarcoma, especially in poorly differentiated or soft tissue locations 4

Anatomic Location Affects Marker Expression

  • Retroperitoneal leiomyosarcomas show the highest expression of caldesmon and myosin (94%) 3
  • External soft tissue leiomyosarcomas are frequently h-caldesmon negative and may show less consistent smooth muscle marker expression 4, 3
  • Gastroesophageal junction location requires particular attention to exclude GIST, as both can present as hypoechoic fourth-layer masses on endoscopic ultrasound 1

Desmin Expression Variability

  • While desmin is traditionally considered a smooth muscle marker, only 2-4% of GISTs express desmin, making its presence helpful but not diagnostic 1
  • Approximately 30% of CD117-negative GISTs may express desmin, particularly in gastric locations with epithelioid morphology 1

Morphologic Correlation is Essential

  • Leiomyosarcomas show spindle cell morphology similar to GIST, making immunohistochemistry mandatory for definitive diagnosis 1
  • The presence of fascicular arrangement of spindle cells supports leiomyosarcoma when combined with appropriate immunoprofile 1

Differential Diagnosis Considerations at the Gastroesophageal Junction

  • GIST remains the primary differential diagnosis and is distinguished by CD117 and/or DOG1 positivity with variable CD34 expression 1
  • Schwannomas express S-100 protein and are negative for desmin and smooth muscle actin 1
  • Inflammatory fibroid polyps are CD34-positive but CD117-negative 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Expression of myogenic marker proteins in human leiomyosarcoma.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.